Amplifying the ADC Advantage: ADCs as the Next Frontier in Precision Lung Cancer Care

Chair, Stephen V. Liu, MD, Melissa L. Johnson, MD, Benjamin Levy, MD, and Prof. Solange Peters, MD, PhD, discuss NSCLC in this CME/MOC/AAPA activity titled “Amplifying the ADC Advantage: How to Fulfill the Potential of Antibody-Drug Conjugates as the Next Frontier in Precision Lung Cancer Care.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/YEN865. CME/MOC/AAPA credit will be available until July 3, 2024.